US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Respiratory/Pulmonary Market Research Reports & Industry Analysis

RSS Feeds

Respiratory/Pulmonary Industry Research & Market Reports

1    3    5  6  7  8  9  10  
Cold and Flu Drugs Markets in China
3/18/2016 | published by: Asia Market Information & Development Company
... to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new ...  |  read more...
USD 4,000
Lung Cancer Treatment Drugs Markets in China
3/18/2016 | published by: Asia Market Information & Development Company
... to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new ...  |  read more...
USD 4,000
Respiratory Drugs Industry Forecasts - China Focus
4/1/2016 | published by: Asia Market Information & Development Company
... the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, ...  |  read more...
USD 1,000
2016-2020 Spain Respiratory Diseases Diagnostic Testing Market: Emerging Opportunities and Growth Strategies for Suppliers
3/15/2016 | published by: VPGMarketResearch.com
... forecasts and supplier shares for Adenovirus , Influenza , Legionella , Mononucleosis , Mycoplasma , Pneumonia, RSV and Tuberculosis . The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition ...  |  read more...
USD 1,950
2016-2020 UK Respiratory Diseases Diagnostic Testing Market: Emerging Opportunities and Growth Strategies for Suppliers
3/15/2016 | published by: VPGMarketResearch.com
... forecasts and supplier shares for Adenovirus , Influenza , Legionella , Mononucleosis , Mycoplasma , Pneumonia , RSV and Tuberculosis . The report provides test volume and sales projections for Hospitals, Commercial and Public Health ...  |  read more...
USD 1,950
Respiratory Drugs Markets in China
4/1/2016 | published by: Asia Market Information & Development Company
... economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic ...  |  read more...
USD 4,000
Respiratory Drugs Companies in China
4/1/2016 | published by: Asia Market Information & Development Company
... of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the ...  |  read more...
USD 1,800
Acute Respiratory Distress Syndrome - Pipeline Review, H1 2016
2/29/2016 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutics under development for Acute Respiratory Distress Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The ...  |  read more...
USD 2,000
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Review, H1 2016
3/9/2016 | published by: Global Markets Direct
... Acute Respiratory Syndrome (SARS) Coronavirus Infection pipeline landscape. The report provides comprehensive information on the therapeutics under development for Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection, complete with analysis by stage of development, drug target, ...  |  read more...
USD 2,000
Neonatal Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2016
2/29/2016 | published by: GlobalData
... scenario. This report provides top line data relating to the clinical trials on Neonatal Respiratory Distress Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. ...  |  read more...
USD 2,500
Leprosy Global Clinical Trials Review, H1, 2016
2/29/2016 | published by: GlobalData
... the clinical trials on Leprosy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 ...  |  read more...
USD 2,500
Bronchospasm Global Clinical Trials Review, H1, 2016
2/29/2016 | published by: GlobalData
... the clinical trials on Bronchospasm. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 ...  |  read more...
USD 2,500
2016-2020 Emerging US Respiratory Disease Testing Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis - Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts
3/11/2016 | published by: VPGMarketResearch.com
... provides analysis of the US respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of ...  |  read more...
USD 4,600
2016-2020 Global Respiratory Disease Testing Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis - France, Germany, Italy, Japan, Spain, UK, US
3/22/2016 | published by: VPGMarketResearch.com
... of the global respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Respiratory ...  |  read more...
USD 9,850
Pulmonary Embolism - Pipeline Review, H1 2016
3/16/2016 | published by: Global Markets Direct
... therapeutics under development for Pulmonary Embolism, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ...  |  read more...
USD 2,000
Bronchopulmonary Dysplasia Global Clinical Trials Review, H1, 2016
3/11/2016 | published by: GlobalData
... line data relating to the clinical trials on Bronchopulmonary Dysplasia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ...  |  read more...
USD 2,500
Bronchitis Treatment - Global Market Outlook (2015-2022)
3/18/2016 | published by: Stratistics Market Research Consulting
... $XX million by 2022. Sedentary lifestyle, chemical pollutants, strict regulations to pollutant emission control, habit to cigarette smoke and adherence to a variety of international protocol are the major factors driving the market growth. Chemicals, ...  |  read more...
USD 4,150
Global Respiratory Syncytial Virus Partnering 2010-2016
4/1/2016 | published by: Current Partnering
... in partnering deals Top deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the ...  |  read more...
USD 1,495
Global Pneumonia Partnering 2010-2016
4/1/2016 | published by: Current Partnering
... deals Top deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading ...  |  read more...
USD 1,495
UK Lung Cancer Market and Competitive Landscape Highlights – 2016
4/1/2016 | published by: Fore Pharma
... Lung Cancer epidemiology, Lung Cancer market valuations and forecast, Lung Cancer products sales and competitive landscape in UK. classified into nine sections – Lung Cancer overview including etiology, pathophysiology, and diagnosis, Lung Cancer treatment options, ...  |  read more...
USD 990
US Lung Cancer Market and Competitive Landscape Highlights – 2016
4/1/2016 | published by: Fore Pharma
... Lung Cancer epidemiology, Lung Cancer market valuations and forecast, Lung Cancer products sales and competitive landscape in the US. classified into nine sections – Lung Cancer overview including etiology, pathophysiology, and diagnosis, Lung Cancer treatment ...  |  read more...
USD 990
Pertussis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
1/1/2016 | published by: DelveInsight
... objective of the Pertussis Report is to understand the market and pipeline status of the drugs around the Pertussis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline ...  |  read more...
USD 2,000
Pulmonary Edema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
1/1/2016 | published by: DelveInsight
... key objective of the Pulmonary Edema Report is to understand the market and pipeline status of the drugs around the Pulmonary Edema to explore the generic development opportunities, licensing opportunities and to gain competitive advantage ...  |  read more...
USD 2,000
Pulmonary Embolism-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
1/1/2016 | published by: DelveInsight
... key objective of the Pulmonary Embolism Report is to understand the market and pipeline status of the drugs around the Pulmonary Embolism to explore the generic development opportunities, licensing opportunities and to gain competitive advantage ...  |  read more...
USD 2,000
Respiratory Distress Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
1/1/2016 | published by: DelveInsight
... A key objective of the Respiratory Distress Syndrome Report is to understand the market and pipeline status of the drugs around the Respiratory Distress Syndrome to explore the generic development opportunities, licensing opportunities and to ...  |  read more...
USD 2,000
1    3    5  6  7  8  9  10